M1 Kliniken AG Stock
Price
Target price
€16.15
€16.15
-2.130%
-0.35
-2.130%
-
19.07.24 / Tradegate
WKN: A0STSQ / Name: M1 Kliniken / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
M1 Kliniken AG Stock
A loss of -2.130% shows a downward development for M1 Kliniken AG.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for M1 Kliniken AG stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of M1 Kliniken AG in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of M1 Kliniken AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| M1 Kliniken AG | -2.130% | -6.377% | -9.014% | 103.914% | 45.495% | 63.793% | - |
| Vita 34 AG | 0.900% | 0.000% | -6.303% | -10.621% | -14.885% | -73.293% | -62.833% |
| Mediclin AG | -4.580% | 5.691% | 5.691% | -13.907% | -2.256% | -35.000% | -49.020% |
| Surgery Partners Inc | - | 8.130% | 16.667% | -25.698% | -7.639% | -46.800% | 336.710% |
News
EQS-News: M1 Kliniken AG: Management Board confirms growth targets
EQS-News: M1 Kliniken AG: Management Board confirms growth targets
EQS-News: M1 Kliniken announces change in the Management Board and confirms long-term growth strategy
EQS-News: M1 Kliniken announces change in the Management Board and confirms long-term growth strategy
EQS-News: M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024
EQS-News: M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024